Literature DB >> 3572790

Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.

S Nattel.   

Abstract

The purpose of these experiments was to evaluate the relationship between interval dependent effects of antiarrhythmic drugs on conduction time and Vmax in canine cardiac Purkinje fibers. Standard microelectrode techniques were used to monitor action potential characteristics at two sites along a canine cardiac false tendon and to measure interelectrode conduction time. The maximum rate of voltage rise during phase 0 (Vmax) and conduction time were independent of diastolic interval under control conditions. In the presence of local anesthetic drugs, recovery from drug-induced depression of Vmax and conduction were first order processes with recovery time constants (mean +/- S.D. in seconds) of 0.14 +/- 0.02 (for Vmax) and 0.15 +/- 0.04 (for conduction time) for lidocaine; 0.17 +/- 0.04 and 0.18 +/- 0.05, respectively, for mexiletine; 0.26 +/- 0.05 and 0.27 +/- 0.07 for amitriptyline; and 1.01 +/- 0.31 and 1.00 +/- 0.32 for procainamide. The kinetics of onset of block were studied using a 30-sec pause, followed by a pacing cycle length of 300 msec (for procainamide) or 1 sec (for quinidine). The onset time constants averaged 2.66 +/- 0.53 pulses (for Vmax) and 2.49 +/- 0.42 pulses (for conduction time) in the presence of procainamide; and 4.02 +/- 1.33 pulses (for Vmax) and 3.86 +/- 1.22 pulses (for conduction time) in the presence of quinidine. These experiments show that local anesthetic drugs produce use dependent changes in conduction time in vitro with time constants comparable to simultaneously measured time constants for effects on Vmax. They imply that the use dependence of drug effects on cardiac conduction can be studied quantitatively in vivo by studying the response to changes in activation frequency.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572790

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Characterization of concentration- and use-dependent effects of quinidine from conduction delay and declining conduction velocity in canine Purkinje fibers.

Authors:  D L Packer; A O Grant; H C Strauss; C F Starmer
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

2.  Application of quinidine on rat sciatic nerve decreases the amplitude and increases the latency of evoked responses.

Authors:  Kuang-I Cheng; I-Ling Lin; Lin-Li Chang; I-Ming Jou; Chung-Sheng Lai; Jhi-Joung Wang; Hung-Chen Wang; Aij-Lie Kwan
Journal:  J Anesth       Date:  2013-12-15       Impact factor: 2.078

3.  Direct quantification of apparent binding indices from quinidine-induced in vivo conduction delay in canine myocardium.

Authors:  F N Haugland; S B Johnson; D L Packer
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

4.  Phase 1A safety assessment of intravenous amitriptyline.

Authors:  Peter Fridrich; Hans Peter Colvin; Anthony Zizza; Ajay D Wasan; Jean Lukanich; Philipp Lirk; Alois Saria; Gerald Zernig; Thomas Hamp; Peter Gerner
Journal:  J Pain       Date:  2007-05-23       Impact factor: 5.820

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.